{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T05:24:56Z","timestamp":1732253096784,"version":"3.28.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,21]]},"DOI":"10.7759\/cureus.74159","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:03:53Z","timestamp":1732205033000},"source":"Crossref","is-referenced-by-count":0,"title":["The Prevalence of Potentially Inappropriate Medications Among Patients With Diabetic Nephropathy: A Cross-Sectional Study Conducted at a Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Mehr","family":"Nisa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Naseralallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Altarawneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roaa","family":"Ally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Danjuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng Y","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018, 14:88-98. 10.1038\/nrendo.2017.151","journal-title":"Nat Rev Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.07.002","article-title":"Diabetic nephropathy: perspective on novel molecular mechanisms","volume":"27","author":"Gnudi L","year":"2016","unstructured":"Gnudi L, Coward RJ, Long DA. Diabetic nephropathy: perspective on novel molecular mechanisms. Trends Endocrinol Metab. 2016, 27:820-30. 10.1016\/j.tem.2016.07.002","journal-title":"Trends Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1122898","article-title":"Prevalence and global trends of polypharmacy in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"14","author":"Naseralallah L","year":"2023","unstructured":"Naseralallah L, Khatib M, Al-Khulaifi A, Danjuma M. Prevalence and global trends of polypharmacy in patients with chronic kidney disease: a systematic review and meta-analysis. Front Pharmacol. 2023, 14:1122898. 10.3389\/fphar.2023.1122898","journal-title":"Front Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2012.01.005","article-title":"Outcomes of polypharmacy in nursing home residents","volume":"28","author":"Tamura BK","year":"2012","unstructured":"Tamura BK, Bell CL, Inaba M, Masaki KH. Outcomes of polypharmacy in nursing home residents. Clin Geriatr Med. 2012, 28:217-36. 10.1016\/j.cger.2012.01.005","journal-title":"Clin Geriatr Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05150418","article-title":"Clinical pharmacokinetics in kidney disease: application to rational design of dosing regimens","volume":"13","author":"Roberts DM","year":"2018","unstructured":"Roberts DM, Sevastos J, Carland JE, Stocker SL, Lea-Henry TN. Clinical pharmacokinetics in kidney disease: application to rational design of dosing regimens. Clin J Am Soc Nephrol. 2018, 13:1254-63. 10.2215\/CJN.05150418","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","unstructured":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023, 71:2052-81. 10.1111\/jgs.18372","journal-title":"J Am Geriatr Soc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O'Mahony D","year":"2015","unstructured":"O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015, 44:213-8. 10.1093\/ageing\/afu145","journal-title":"Age Ageing"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2012-130889","article-title":"The prevalence of potentially inappropriate medication prescribing in elderly patients with chronic kidney disease","volume":"89","author":"Jones SA","year":"2013","unstructured":"Jones SA, Bhandari S. The prevalence of potentially inappropriate medication prescribing in elderly patients with chronic kidney disease. Postgrad Med J. 2013, 89:247-50. 10.1136\/postgradmedj-2012-130889","journal-title":"Postgrad Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.03.019","article-title":"Risk of potentially inappropriate medications in adults with CKD: findings from the chronic renal insufficiency cohort (CRIC) study","volume":"78","author":"Hall RK","year":"2021","unstructured":"Hall RK, Blumenthal JB, Doerfler RM, et al.. Risk of potentially inappropriate medications in adults with CKD: findings from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2021, 78:837-45.e1. 10.1053\/j.ajkd.2021.03.019","journal-title":"Am J Kidney Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05557-810","article-title":"Use of potentially nephrotoxic medications by U.S. adults with chronic kidney disease: NHANES, 2011-2016","volume":"35","author":"Kurani S","year":"2020","unstructured":"Kurani S, Jeffery MM, Thorsteinsdottir B, et al.. Use of potentially nephrotoxic medications by U.S. adults with chronic kidney disease: NHANES, 2011-2016. J Gen Internal Med. 2020, 35:1092-101. 10.1007\/s11606-019-05557-810","journal-title":"J Gen Internal Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030783","article-title":"Medication prescribing quality in Australian primary care patients with chronic kidney disease","volume":"9","author":"Bezabhe WM","year":"2020","unstructured":"Bezabhe WM, Kitsos A, Saunder T, et al.. Medication prescribing quality in Australian primary care patients with chronic kidney disease. J Clin Med. 2020, 9:1092-101. 10.3390\/jcm9030783","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.01.334","article-title":"POS-314 polypharmacy and potentially inappropriate medication use in patients with CKD managed in Canadian primary care","volume":"7","author":"Tinwala M","unstructured":"Tinwala M, Zaidi D, Ye F, et al.. POS-314 polypharmacy and potentially inappropriate medication use in patients with CKD managed in Canadian primary care. Kidney Int Rep. 314, 7:2. 10.1016\/j.ekir.2022.01.334","journal-title":"Kidney Int Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5414\/CN110808","article-title":"Potentially inappropriate medication in patients with chronic kidney disease and elderly patients","volume":"98","author":"L\u00fcthke N","year":"2022","unstructured":"L\u00fcthke N, Scheuch M, Enge\u00dfer J, et al.. Potentially inappropriate medication in patients with chronic kidney disease and elderly patients. Clin Nephrol. 2022, 98:42-8. 10.5414\/CN110808","journal-title":"Clin Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal B","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, et al.. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017, 377:644-57. 10.1056\/NEJMoa1611925","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18084370","article-title":"Pharmacist\u2010led collaborative medication management for the elderly with chronic kidney disease and polypharmacy","volume":"18","author":"Kim AJ","year":"2021","unstructured":"Kim AJ, Lee H, Shin EJ, Cho EJ, Cho YS, Lee H, Lee JY. Pharmacist\u2010led collaborative medication management for the elderly with chronic kidney disease and polypharmacy. Int J Environ Res Public Health. 2021, 18:4370. 10.3390\/ijerph18084370","journal-title":"Int J Environ Res Public Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2174\/1874609814666210719113157","article-title":"Chronic kidney disease (CKD) - a brand ambassador\/alarming bell for potentially inappropriate medication in elderly inpatients","volume":"15","author":"Sharma R","year":"2022","unstructured":"Sharma R, Bansal P, Chhabra M, Arora M. Chronic kidney disease (CKD) - a brand ambassador\/alarming bell for potentially inappropriate medication in elderly inpatients. Curr Aging Sci. 2022, 15:59-64. 10.2174\/1874609814666210719113157","journal-title":"Curr Aging Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/319415-the-prevalence-of-potentially-inappropriate-medications-among-patients-with-diabetic-nephropathy-a-cross-sectional-study-conducted-at-a-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:03:54Z","timestamp":1732205034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/319415-the-prevalence-of-potentially-inappropriate-medications-among-patients-with-diabetic-nephropathy-a-cross-sectional-study-conducted-at-a-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.74159","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}